GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Photocure A PHO.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

42.10

-5.61%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in NOK, from our data supplier.

FY2025

Revenue

NOK 532.6m

FY2016FY2025

Net income

−NOK 1.5m

FY2016FY2025

Free cash flow

NOK 5.3m

FY2016FY2025

Shareholders' equity

NOK 484.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueNOK 532.6mNOK 525.4mNOK 500.7mNOK 393.1mNOK 360.5mNOK 256.5mNOK 281.6mNOK 181.5mNOK 150.9mNOK 143.6m
Gross profitNOK 490.6mNOK 494.7mNOK 474.5mNOK 370.4mNOK 336.5mNOK 238.0mNOK 259.0mNOK 164.4mNOK 138.9mNOK 134.3m
Research and developmentNOK 402,000NOK 3.6mNOK 2.1mNOK 3.3mNOK 4.3mNOK 13.8mNOK 13.6mNOK 19.1mNOK 32.6mNOK 23.0m
Operating income−NOK 745,000NOK 23.6mNOK 27.8m−NOK 49.0mNOK 9.4m−NOK 31.1mNOK 42.7m−NOK 37.9m−NOK 45.2m−NOK 15.9m
Net income−NOK 1.5m−NOK 3.3mNOK 979,000−NOK 71.9m−NOK 30.9m−NOK 22.4mNOK 31.8m−NOK 36.7m−NOK 34.7mNOK 35.3m
Diluted earnings per share-0.06-0.120.04-2.65-1.14-0.831.18-1.36-1.291.31

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsNOK 707.1mNOK 739.1mNOK 712.0mNOK 719.0mNOK 789.6mNOK 776.0mNOK 257.4mNOK 231.2mNOK 263.1mNOK 285.9m
Cash and short-term investmentsNOK 238.9mNOK 288.8mNOK 256.3mNOK 264.7mNOK 319.0mNOK 329.5mNOK 121.2mNOK 102.5mNOK 125.3mNOK 165.3m
Total liabilitiesNOK 222.8mNOK 237.4mNOK 229.1mNOK 256.3mNOK 287.0mNOK 267.9mNOK 48.8mNOK 54.9mNOK 45.0mNOK 33.9m
DebtNOK 100.1mNOK 26.4mNOK 28.0mNOK 48.6mNOK 72.9mNOK 53.9mNOK 6.9m———
Shareholders' equityNOK 484.2mNOK 501.7mNOK 482.8mNOK 462.7mNOK 502.6mNOK 508.1mNOK 208.6mNOK 176.3mNOK 218.1mNOK 251.9m
Shares outstanding27m27m27m27m27m27m27m27m27m27m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsNOK 26.0mNOK 76.8mNOK 29.4m−NOK 2.0mNOK 23.9mNOK 15.6mNOK 20.7m−NOK 24.1m−NOK 23.6mNOK 19.2m
Capital spending−NOK 20.7m−NOK 11.4m−NOK 11.4m−NOK 3.6m−NOK 3.7m−NOK 1.6m−NOK 1.2m−NOK 2.2m−NOK 18.6m−NOK 22.1m
Free cash flowNOK 5.3mNOK 65.3mNOK 18.0m−NOK 5.6mNOK 20.2mNOK 14.0mNOK 19.4m−NOK 26.3m−NOK 42.2m−NOK 2.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueNOK 142.5mNOK 264.6mNOK 136.7mNOK 135.0mNOK 135.6mNOK 125.3mNOK 141.7mNOK 120.2m
Gross profitNOK 132.1mNOK 254.3mNOK 125.7mNOK 123.1mNOK 125.6mNOK 116.2mNOK 134.2mNOK 112.4m
Operating income−NOK 9.4mNOK 120.7m−NOK 5.5mNOK 2.9mNOK 7.5m−NOK 5.6mNOK 1.2m−NOK 2.2m
Net income−NOK 709,000NOK 83.4m−NOK 8.0mNOK 4.0mNOK 4.9m−NOK 2.4m−NOK 4.3m−NOK 3.5m
Diluted earnings per share-0.033.14-0.300.150.18-0.09-0.16-0.13
Cash from operationsNOK 62.0m—NOK 25.0mNOK 26.0m−NOK 2.0mNOK 4.0mNOK 76.0mNOK 61.0m
Capital spending−NOK 5.0m−NOK 7.0m−NOK 20.0m−NOK 16.0m−NOK 5.0m−NOK 2.0m−NOK 11.0m−NOK 7.0m
Free cash flowNOK 57.0m—NOK 5.0mNOK 10.0m−NOK 7.0mNOK 2.0mNOK 65.0mNOK 54.0m
Total assetsNOK 901.4mNOK 786.0mNOK 707.1mNOK 696.7mNOK 685.4mNOK 708.6mNOK 739.1mNOK 720.5m
Cash and short-term investments——NOK 238.9mNOK 247.8mNOK 239.1mNOK 259.5mNOK 293.9mNOK 291.1m
Debt——NOK 100.1m—————
Shareholders' equityNOK 606.7mNOK 577.9mNOK 484.2mNOK 486.6mNOK 479.8mNOK 471.8mNOK 501.7mNOK 499.7m

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin92.1%94.2%94.8%94.2%93.3%92.8%——
Operating margin1.5%3.9%5.6%-12.5%2.6%-5.2%——
Net margin-0.3%-0.6%0.2%-18.3%-8.6%-8.7%——
Return on equity-0.3%-0.7%0.2%-15.5%-6.1%-4.4%——
Return on assets-0.2%-0.5%0.1%-10.0%-3.9%-2.9%——
Free cash flow yield——3.3%0.1%2.2%1.4%1.8%-1.8%
Revenue growth1.4%4.9%27.4%9.0%40.6%-8.9%——
Earnings growth-54.5%-441.1%-101.4%132.6%37.9%-170.4%——
Current ratio3.64x4.08x4.48x3.44x3.64x5.17x——
Debt to equity0.21x0.23x0.00x0.04x0.09x0.10x——
Equity ratio68.5%67.9%67.8%64.4%63.7%65.5%——
Interest coverage0.24x0.73x1.06x-1.90x0.39x-1.90x——
R&D as a share of sales0.1%0.7%0.4%0.9%1.2%5.4%——
Buybacks as a share of market value——0.8%-0.2%-0.8%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.6%15.7%14.7%
Operating income-75.2%-52.6%-28.7%
Net income-72.4%-41.6%-27.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin93.1%93.8%93.6%93.3%
Operating margin2.2%0.1%-0.8%-2.8%
Net margin-0.5%-3.9%-5.0%-4.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1229.2-503.3—-40.4-90.1-128.075.6-35.2-21.232.0
Price to sales3.53.23.67.47.711.28.67.14.97.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 23 May 2013.

FY2013FY2009
Paid in the year2.004.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.